LEM Surgical, a Bern, Switzerland-based startup focused on surgical robotic solutions for spinal surgery, raised CHF 8.7M in Series A funding.
The round was led by Ypsomed Group CEO Simon Michel.
The company intends to use the funds to to develop its product further and prepare relevant documentation to be submitted to the US FDA in early 2024.
Founded in June 2021 by Stefan Weber (CEO, CAScination AG), Andreas Raabe (Director, Department of Neurosurgery, Inselspital Bern), Marco Matulic (CTO CAScination AG), Simon Michel (CEO, Ypsomed Group) and Yossi Bar (previously Director R&D at Mazor Robotics Ltd., sold to Medtronic in 2018), Lem aims to deliver solutions for patients in the field of orthopaedic and especially spinal surgery.
FinSMEs
03/01/2022